Evaluation of milk protein concentrate (MPC) on weight-loss

Not Applicable

Recruiting

Conditions: Obesity due to excess calories
E66.0
Obesity.

Registration Number: IRCT20201223049804N1

Lead Sponsor: Ahvaz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 44

Inclusion Criteria

aged 18 years and older
female
BMI range of 30 to 40 kg/m2
absence of menopause, lactation and pregnancy
food allergies
not having eating disorders, particularly binge eating disorder (BED), bulimia
not having cancer, hepatic, renal, thyroid and gastrointestinal disorders
no surgery for weight loss
no weight loss over the past 6 months
no taking herbs and drug that reduce appetite and weight and vitamin-mineral supplements

Exclusion Criteria

become pregnant during study
unwilling to continue
changes in diet during the study period
no consumption of powders exceed 10% of total administered powders

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eptin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Adiponectin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Body Composition. Timepoint: Before and 2 months after the intervention. Method of measurement: Body Composition Analyzer.;Waist circumference. Timepoint: Before and 2 months after the intervention. Method of measurement: Tape measure.;Body Mass Index. Timepoint: Before and 2 months after the intervention. Method of measurement: calculated as body weight(kg)divided by the height in meters square.

Secondary Outcome Measures

Name	Time	Method
Fasting Blood Sugar. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Lipid Profile. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Fasting Plasma Insulin. Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Timepoint: Before and 2 months after the intervention. Method of measurement: Bloodletting.;Appetite. Timepoint: Before and 2 months after the intervention. Method of measurement: Questionnaire.